Payment overview · 2025
General Payments
$15.99
1 reported records · 1 companies
Healthcare provider profile · identity verified
Matthew Christopher Meyer, MD
Allopathic & Osteopathic Physicians|Internal Medicine · CARLISLE, PA · NPI 1568669133
Verified facts
What the public records show
CMS Open Payments records show Matthew Christopher Meyer, MD received $15.99 in general payments during 2025 across 1 reported records.
AstraZeneca Pharmaceuticals LP accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Farxiga by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $15.99 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $15.99 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $15.99 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 714 | 203 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 651 | 166 |
| Lisinopril | Lisinopril | 523 | 130 |
| Losartan Potassium | Losartan Potassium | 517 | 129 |
| Amlodipine Besylate | Amlodipine Besylate | 511 | 140 |
| Levothyroxine Sodium | Levothyroxine Sodium | 488 | 120 |
| Omeprazole | Omeprazole | 404 | 96 |
| Metformin Hcl | Metformin Hcl | 372 | 92 |
| Hydrochlorothiazide | Hydrochlorothiazide | 355 | 100 |
| Metoprolol Succinate | Metoprolol Succinate | 315 | 79 |
| Sertraline Hcl | Sertraline Hcl | 293 | 73 |
| Glipizide Er | Glipizide | 285 | 60 |
| Duloxetine Hcl | Duloxetine Hcl | 281 | 55 |
| Gabapentin | Gabapentin | 281 | 64 |
| Furosemide | Furosemide | 245 | 60 |
| Pantoprazole Sodium | Pantoprazole Sodium | 236 | 67 |
| Trazodone Hcl | Trazodone Hcl | 228 | 54 |
| Eliquis | Apixaban | 215 | 42 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 192 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 184 | 47 |
| Ezetimibe | Ezetimibe | 164 | 40 |
| Fluticasone Propionate | Fluticasone Propionate | 147 | 46 |
| Jardiance | Empagliflozin | 141 | 41 |
| Simvastatin | Simvastatin | 139 | 33 |
| Citalopram Hbr | Citalopram Hydrobromide | 138 | 30 |
| Allopurinol | Allopurinol | 136 | 31 |
| Metoprolol Tartrate | Metoprolol Tartrate | 132 | 37 |
| Meloxicam | Meloxicam | 130 | 35 |
| Carvedilol | Carvedilol | 129 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 127 | 33 |
| Ozempic | Semaglutide | 120 | 25 |
| Mirtazapine | Mirtazapine | 117 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 114 | 32 |
| Metformin Hcl Er | Metformin Hcl | 110 | 30 |
| Montelukast Sodium | Montelukast Sodium | 105 | 26 |
| Famotidine | Famotidine | 104 | 27 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 101 | 17 |
| Bupropion Hcl Sr | Bupropion Hcl | 100 | 22 |
| Lorazepam | Lorazepam | 99 | 27 |
| Buspirone Hcl | Buspirone Hcl | 96 | 21 |
| Atenolol | Atenolol | 95 | 22 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 94 | 17 |
| Potassium Chloride | Potassium Chloride | 93 | 23 |
| Tramadol Hcl | Tramadol Hcl | 92 | 24 |
| Pioglitazone Hcl | Pioglitazone Hcl | 87 | 19 |
| Clonidine Hcl | Clonidine Hcl | 84 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 84 | 26 |
| Synthroid | Levothyroxine Sodium | 83 | 24 |
| Fluoxetine Hcl | Fluoxetine Hcl | 80 | 17 |
| Trulicity | Dulaglutide | 76 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 76 | 18 |
| Prednisone | Prednisone | 75 | 52 |
| Topiramate | Topiramate | 71 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 68 | 47 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 68 | 17 |
| Warfarin Sodium | Warfarin Sodium | 64 | 15 |
| Breo Ellipta | Fluticasone/Vilanterol | 60 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 60 | suppressed |
| Celecoxib | Celecoxib | 59 | 18 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 59 | suppressed |
| Pregabalin | Pregabalin | 59 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 57 | 17 |
| Januvia | Sitagliptin Phosphate | 56 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 55 | 16 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 55 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 53 | 17 |
| Nifedipine Er | Nifedipine | 52 | 12 |
| Midodrine Hcl | Midodrine Hcl | 51 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 50 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 49 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 48 | 35 |
| Irbesartan | Irbesartan | 48 | 12 |
| Propranolol Hcl | Propranolol Hcl | 48 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 48 | 37 |
| Finasteride | Finasteride | 47 | 15 |
| Oxycodone Hcl | Oxycodone Hcl | 47 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 46 | 16 |
| Fenofibrate | Fenofibrate | 45 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 45 | suppressed |
| Glipizide | Glipizide | 44 | 12 |
| Azelastine Hcl | Azelastine Hcl | 43 | 12 |
| Tradjenta | Linagliptin | 43 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 42 | suppressed |
| Azithromycin | Azithromycin | 41 | 38 |
| Clonazepam | Clonazepam | 41 | suppressed |
| Xarelto | Rivaroxaban | 41 | suppressed |
| Alprazolam | Alprazolam | 40 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 40 | suppressed |
| Bumetanide | Bumetanide | 39 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 39 | 13 |
| Nortriptyline Hcl | Nortriptyline Hcl | 38 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 38 | 24 |
| Benazepril Hcl | Benazepril Hcl | 37 | 11 |
| Sumatriptan Succinate | Sumatriptan Succinate | 37 | suppressed |
| Spironolactone | Spironolactone | 36 | 12 |
| Ventolin Hfa | Albuterol Sulfate | 35 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 34 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 34 | suppressed |
| Novolog Flexpen | Insulin Aspart | 34 | suppressed |
| Glimepiride | Glimepiride | 33 | suppressed |
| Naproxen | Naproxen | 33 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 33 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 31 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 31 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 31 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 30 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 30 | suppressed |
| Levetiracetam | Levetiracetam | 29 | suppressed |
| Temazepam | Temazepam | 29 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 28 | suppressed |
| Chlorthalidone | Chlorthalidone | 27 | suppressed |
| Rybelsus | Semaglutide | 27 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 27 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 27 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 26 | suppressed |
| Ondansetron Odt | Ondansetron | 26 | suppressed |
| Primidone | Primidone | 26 | suppressed |
| Linzess | Linaclotide | 25 | suppressed |
| Bupropion Xl | Bupropion Hcl | 24 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 24 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 23 | suppressed |
| Memantine Hcl | Memantine Hcl | 23 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 23 | suppressed |
| Nystatin | Nystatin | 23 | suppressed |
| Nitroglycerin | Nitroglycerin | 22 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 21 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 21 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 21 | 17 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 21 | suppressed |
| Aripiprazole | Aripiprazole | 20 | suppressed |
| Baclofen | Baclofen | 20 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 20 | suppressed |
| Klor-Con M20 | Potassium Chloride | 20 | suppressed |
| Lamotrigine | Lamotrigine | 19 | suppressed |
| Latuda | Lurasidone Hcl | 19 | suppressed |
| Mounjaro | Tirzepatide | 19 | suppressed |
| Fluconazole | Fluconazole | 18 | suppressed |
| Premarin | Estrogens, Conjugated | 18 | suppressed |
| Zonisamide | Zonisamide | 18 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 17 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 17 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 17 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 17 | suppressed |
| Methocarbamol | Methocarbamol | 17 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 17 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 17 | suppressed |
| Zafirlukast | Zafirlukast | 17 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 16 | suppressed |
| Cephalexin | Cephalexin | 16 | 12 |
| Diazepam | Diazepam | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Lovastatin | Lovastatin | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | 12 |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 15 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 15 | suppressed |
| Movantik | Naloxegol Oxalate | 15 | suppressed |
| Ramipril | Ramipril | 15 | suppressed |
| Victoza 3-Pak | Liraglutide | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 14 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Methylprednisolone | Methylprednisolone | 14 | 13 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Amoxicillin | Amoxicillin | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 13 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 13 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Lactulose | Lactulose | 13 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 13 | suppressed |
| Prempro | Estrogen,con/M-Progest Acet | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 12 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 12 | suppressed |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 12 | suppressed |
| Aciphex | Rabeprazole Sodium | 11 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 11 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 11 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $15.99 · 1 records | AstraZeneca Pharmaceuticals LP | BREZTRI | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error